- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2012
- Public Summary Document (PSD) July 2012 PBAC Meeting - PDF
Vemurafenib – July 2012
Vemurafenib, tablet, 240 mg, Zelboraf®
Last updated
8 November 2023